PT833902E - Oligonucleotidos especificos para o virus da hepatite c - Google Patents
Oligonucleotidos especificos para o virus da hepatite cInfo
- Publication number
- PT833902E PT833902E PT96920788T PT96920788T PT833902E PT 833902 E PT833902 E PT 833902E PT 96920788 T PT96920788 T PT 96920788T PT 96920788 T PT96920788 T PT 96920788T PT 833902 E PT833902 E PT 833902E
- Authority
- PT
- Portugal
- Prior art keywords
- hepatitis
- virus
- specific oligonucleotides
- oligonucleotides
- specific
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
- C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/33—Chemical structure of the base
- C12N2310/334—Modified C
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/346—Spatial arrangement of the modifications having a combination of backbone and sugar modifications
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Analytical Chemistry (AREA)
- Plant Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47196895A | 1995-06-06 | 1995-06-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT833902E true PT833902E (pt) | 2003-09-30 |
Family
ID=23873702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT96920788T PT833902E (pt) | 1995-06-06 | 1996-06-04 | Oligonucleotidos especificos para o virus da hepatite c |
Country Status (10)
| Country | Link |
|---|---|
| EP (2) | EP1331267A3 (pt) |
| AR (1) | AR002757A1 (pt) |
| AT (1) | ATE240392T1 (pt) |
| AU (1) | AU6221996A (pt) |
| CA (1) | CA2226438A1 (pt) |
| DE (1) | DE69628167D1 (pt) |
| ES (1) | ES2196157T3 (pt) |
| PT (1) | PT833902E (pt) |
| WO (1) | WO1996039500A2 (pt) |
| ZA (1) | ZA964446B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1002878A3 (en) * | 1998-11-19 | 2003-11-12 | Tosoh Corporation | Hepatitis C Virus RNA-binding oligo DNA and method preparing it |
| ES2288883T3 (es) * | 1999-12-13 | 2008-02-01 | Bioniche Life Sciences Inc. | Oligonucleotidos sinteticos utiles terapeuticamente. |
| SK287689B6 (sk) * | 2000-06-08 | 2011-06-06 | Intercell Ag | Použitie molekuly oligodeoxynukleovej kyseliny na výrobu imunostimulačnej farmaceutickej kompozície a farmaceutický prípravok |
| US6586584B2 (en) | 2001-01-29 | 2003-07-01 | Becton, Dickinson And Company | Sequences and methods for detection of Hepatitis C virus |
| WO2003018747A2 (en) * | 2001-08-22 | 2003-03-06 | Isis Pharmaceuticals, Inc. | Molecular interaction sites of hepatitis c virus rna and methods of modulating the same |
| ES2270656B1 (es) * | 2004-03-25 | 2008-03-16 | Consejo Sup. Investig. Cientificas | Secuencia de rna, construccion de rna y dna, y composicion farmaceutica inhibidoras de la proliferacion del virus causante de la hepatitis tipo c (vhc), y sus aplicaciones. |
| FR2884522A1 (fr) * | 2005-04-19 | 2006-10-20 | Larissa Balakireva | Methode d'inhibition de la traduction et/ou la replication d'une sequence d'arn par multimerisation d'une de ses regions d'arn non codant replie |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE202383T1 (de) * | 1992-09-10 | 2001-07-15 | Isis Pharmaceuticals Inc | Zusammensetzungen und verfahren für die behandlung von mit hepatitis c viren assoziierten krankheiten |
| ATE310817T1 (de) * | 1992-09-28 | 2005-12-15 | Chiron Corp | Verfahren und zusammensetzungen zur kontrolle der übersetzung der hcv-proteine |
| EP0759979A4 (en) * | 1994-05-10 | 1999-10-20 | Gen Hospital Corp | ANTISENSE OLIGONUCLEOTIDES INHIBITION OF HEPATITIS C VIRUS |
-
1996
- 1996-05-30 ZA ZA964446A patent/ZA964446B/xx unknown
- 1996-06-04 AU AU62219/96A patent/AU6221996A/en not_active Abandoned
- 1996-06-04 PT PT96920788T patent/PT833902E/pt unknown
- 1996-06-04 WO PCT/EP1996/002427 patent/WO1996039500A2/en active IP Right Grant
- 1996-06-04 EP EP03005364A patent/EP1331267A3/en not_active Withdrawn
- 1996-06-04 CA CA002226438A patent/CA2226438A1/en not_active Abandoned
- 1996-06-04 ES ES96920788T patent/ES2196157T3/es not_active Expired - Lifetime
- 1996-06-04 EP EP96920788A patent/EP0833902B1/en not_active Expired - Lifetime
- 1996-06-04 DE DE69628167T patent/DE69628167D1/de not_active Expired - Lifetime
- 1996-06-04 AT AT96920788T patent/ATE240392T1/de not_active IP Right Cessation
- 1996-06-04 AR ARP960102904A patent/AR002757A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2196157T3 (es) | 2003-12-16 |
| EP0833902A2 (en) | 1998-04-08 |
| WO1996039500A2 (en) | 1996-12-12 |
| CA2226438A1 (en) | 1996-12-12 |
| ATE240392T1 (de) | 2003-05-15 |
| EP1331267A3 (en) | 2003-12-03 |
| ZA964446B (en) | 1996-12-06 |
| AU6221996A (en) | 1996-12-24 |
| EP0833902B1 (en) | 2003-05-14 |
| WO1996039500A3 (en) | 1997-03-13 |
| DE69628167D1 (de) | 2003-06-18 |
| AR002757A1 (es) | 1998-04-29 |
| EP1331267A2 (en) | 2003-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO954217D0 (no) | Guanosinrike antivirus-oligonukleotider | |
| DE69630044D1 (de) | Viren inaktivierende umhüllungen | |
| PT810877E (pt) | Vacina da hepatite b | |
| NO975731D0 (no) | Katalytisk DNA | |
| DE69624884D1 (de) | Wabenkörper | |
| DE69623905D1 (de) | Hitzebeständiger Katalysatorträger | |
| ATE291038T1 (de) | Polymerisationsverfahren | |
| BR9607626A (pt) | Novos compostos farmacéuticos de naftila | |
| PT833902E (pt) | Oligonucleotidos especificos para o virus da hepatite c | |
| ATE386058T1 (de) | Polymerisationsverfahren | |
| IS4629A (is) | Samskeyttar veirukjarnsýrur | |
| ATE278716T1 (de) | Polymerisationsverfahren | |
| DE69822242D1 (de) | Neisseria gonorrhoae spezifische Oligonukleotide | |
| DE69605733D1 (de) | Katalysatorzusammensetzungen | |
| DE69605256D1 (de) | Katalysatorzusammensetzungen | |
| DE69517403D1 (de) | Lockenwickel | |
| IT1275919B1 (it) | Fotodensitometro parallelo perfezionato | |
| FI944558A0 (fi) | Virus | |
| KR970006539U (ko) | 전자렌지의 히타를 이용한 탈취장치 | |
| FR2736838B1 (fr) | Espalier chauffant | |
| KR960029702U (ko) | 클라이스트론 | |
| SE9502596D0 (sv) | New DNA molecules II | |
| NO955339D0 (no) | Mikrobölge sterilisator | |
| SE9501976D0 (sv) | New DNA molecules | |
| KR970015208U (ko) | 클라이스트론 |